National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Sebelipase alfa is indicated for long-term enzyme replacement therapy (ERT) in patients of all ages with lysosomal acid lipase (LAL) deficiency.

Rapid Review

Commenced Completed Outcome
08/02/2017 15/03/2017 Full Pharmacoeconomic Evaluation Recommended